Glutathione
Also known as: Glutathion, Glutathione, GSH, Isethion, Lycored, Reduced glutathione, Tathion, γ-L-Glutamyl-L-cysteinylglycine
Source Glutathione at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Glutathione is a naturally occurring tripeptide that functions as a cellular antioxidant and is marketed in various forms for skin lightening. Clinical investigations have examined oral capsules (250–500 mg daily), topical creams (0.5–2 % concentrations), and intravenous infusions, primarily aiming to reduce melanin levels in sun‑exposed skin and improve hyperpigmentary conditions such as melasma.
Mechanism of Action
Glutathione acts as a major intracellular antioxidant, scavenging reactive oxygen species and maintaining redox balance. In melanocytes it can inhibit the enzyme tyrosinase, shift melanin synthesis toward the lighter pheomelanin pathway, and reduce oxidative stress that otherwise promotes melanin production. These actions underlie its reported skin‑lightening and anti‑pigmentary effects.
What the Research Shows
A systematic review of four clinical studies (three RCTs) found that oral glutathione at 500 mg/day and topical oxidized glutathione (2 %) modestly reduced skin melanin index in sun‑exposed areas, with trends toward improved wrinkle depth and elasticity. A separate randomized, double‑blind trial (60 participants) reported statistically significant melanin reduction at two sites after 4 weeks of 500 mg daily oral dosing. A more recent systematic review of five RCTs and one open‑label study confirmed significant melanin index reductions with oral doses of 250–500 mg and topical 0.5–2 % formulations, while an IV study showed no clear efficacy and raised safety concerns. Overall, the evidence is limited by small sample sizes, variable study quality, and inconsistent outcomes.
Reported Benefits
Evidence suggests glutathione can produce a modest lightening of skin tone in exposed areas, as measured by melanin index, when administered orally (250–500 mg daily) or topically (0.5–2 %). Some trials also noted possible improvements in skin elasticity, wrinkle depth, and UV spot counts, though these findings are preliminary and not uniformly replicated.
Limitations of the Evidence
The clinical data are limited to a handful of small trials with mixed methodological quality, leading to inconsistent findings. Oral bioavailability is low, and the magnitude of skin lightening is modest. Intravenous glutathione has not demonstrated clear benefit and may carry higher risk. Long‑term safety data are lacking, and most studies focus on short‑term outcomes in healthy volunteers rather than diverse patient populations.
Safety Considerations
Reported adverse events across studies were generally mild and non‑serious, including transient gastrointestinal discomfort and skin irritation with topical use. Intravenous administration was associated with side effects and is considered contraindicated by recent reviews. Because long‑term safety has not been established, caution is advised for prolonged or high‑dose use, especially in individuals with underlying health conditions.
How It Is Administered
Glutathione is available as oral capsules (commonly 250 mg or 500 mg per day), topical creams or gels (0.5 %–2 % concentration), and intravenous solutions (studied but not recommended). Other listed routes such as inhalation, nasal spray, or sublingual formulations exist, though clinical evidence for these routes is currently lacking.
Routes of Administration
Goals & Uses
- Parkinson's disease symptom managementNeurology (investigational)Low
- Immune function enhancementImmunologyLow
- Cisplatin-induced peripheral neuropathy preventionOncology / NeuroprotectionModerate
- Skin brighteningCosmeticLow
- Antioxidant supportOxidative StressHigh
- Skin lightening / hyperpigmentation reductionDermatology (off Label)Low
- Acetaminophen (paracetamol) overdose adjunctToxicologyModerate
- DetoxificationHepaticModerate
- Antioxidant support / oxidative stress reductionGeneral Health / Cellular ProtectionModerate
Contraindications
- Known hypersensitivity to glutathioneAllergyHigh
- Known hypersensitivity to glutathione or formulation excipientsAllergyHigh
- Concurrent chemotherapy regimens where GSH may reduce efficacyOncologyModerate
- Severe asthmaRespiratoryModerate
- Pregnancy (high-dose IV)Reproductive SafetyModerate
Adverse Effects
- Hypersensitivity / allergic reactionsImmunologicRare
- Injection site reactionsLocalCommon
- HeadacheNeurologicCommonPain in the head or upper neck
- Gastrointestinal discomfortGastrointestinalUncommon
- Anaphylactic reactionImmuneRare
- Skin rashDermatologicUncommon
- Thyroid dysfunctionEndocrineRare
- NauseaGastrointestinalCommonFeeling of sickness or urge to vomit
- Stevens-Johnson syndrome / toxic epidermal necrolysisDermatological (severe)Rare
- Renal dysfunction (with high-dose IV)RenalRare
Drug Interactions
- NitroglycerinLow
- WarfarinLow
- Nitroglycerin / Organic nitratesLow
- CisplatinLow
- N-Acetylcysteine (NAC)Low
- Chemotherapy agents (e.g., cisplatin)Moderate
- Alkylating chemotherapy agents (e.g., cyclophosphamide, melphalan)Moderate
Population Constraints
- Patients with cystinuria or cystine kidney stonesMetabolic / RenalRelative
- Pediatric patientsAgeRelative
- Patients undergoing cancer chemotherapyOncologyRelative
- Patients with renal impairmentOrgan ImpairmentRelative
- Pregnant womenReproductiveRelative
- Children under 12PediatricRelative
- Patients with asthma (nebulized route)PulmonaryRelative
Regulatory Status
- European UnionUnapprovedRegulated as food supplement; not authorized as medicinal product
- United StatesUnapprovedAvailable as dietary supplement; IV formulation used under investigational protocols
- United KingdomUnapprovedClassed as a food supplement; IV use limited to clinical trials
Not approved as a prescription drug in the US; marketed as a dietary supplement and as an intravenous preparation for specific clinical uses.
Evidence & Sources
- Journal ArticleHighDilokthornsakul W, Dhippayom T, Dilokthornsakul P2019-01-01T00:00:00.000000Z
- Journal ArticleModerateArjinpathana N, Asawanonda P2012-01-01T00:00:00.000000Z
- Journal ArticleHighJafari A, et al.2024-01-01T00:00:00.000000Z
- Journal ArticleHighLee TM, et al.2021-01-01T00:00:00.000000Z
- Journal ArticleHighTratenšek A, et al.2024-01-01T00:00:00.000000Z
- Journal ArticleHighSarkar R, et al.2025-01-01T00:00:00.000000Z
Frequently Asked Questions
Can glutathione permanently change my skin colour?
Current studies show only modest, short‑term reductions in melanin index, primarily in sun‑exposed areas. Effects tend to diminish after discontinuation, and long‑term outcomes have not been established.
Is oral glutathione effective despite low absorption?
Some trials report modest skin‑lightening with 250–500 mg daily doses, suggesting enough systemic exposure to affect melanogenesis, but bioavailability remains limited and results are variable.
Are there any serious risks with intravenous glutathione?
An IV study reported side effects and failed to demonstrate clear efficacy; recent reviews consider IV glutathione contraindicated due to safety concerns and lack of benefit.
How long does it take to see a skin‑lightening effect?
In the cited randomized trial, measurable melanin reduction was observed after four weeks of daily oral dosing; other studies used similar 4‑ to 8‑week periods to assess outcomes.
Should I combine oral and topical glutathione for better results?
One systematic review noted that combining topical 2 % glutathione with oral supplementation produced greater melanin reduction than either modality alone, but the evidence is limited and should be weighed against cost and potential irritation.
What is Glutathione?
Glutathione is a naturally occurring tripeptide that functions as a cellular antioxidant and is marketed in various forms for skin lightening. Clinical investigations have examined oral capsules (250–500 mg daily), topical creams (0.5–2 % concentrations), and intravenous infusions, primarily aiming to reduce melanin levels in sun‑exposed skin and improve hyperpigmentary conditions such as melasma.
What is Glutathione used for?
Glutathione is educationally associated with: Parkinson's disease symptom management, Immune function enhancement, Cisplatin-induced peripheral neuropathy prevention, Skin brightening, Antioxidant support, Skin lightening / hyperpigmentation reduction, Acetaminophen (paracetamol) overdose adjunct, Detoxification, Antioxidant support / oxidative stress reduction. Educational only — not medical advice.
How is Glutathione administered?
Recorded routes of administration: Inhalation, Intravenous, Nasal, Oral, Sublingual, Topical.
What are the potential side effects of Glutathione?
Reported adverse effects include: Hypersensitivity / allergic reactions, Injection site reactions, Headache, Gastrointestinal discomfort, Anaphylactic reaction, Skin rash, Thyroid dysfunction, Nausea, Stevens-Johnson syndrome / toxic epidermal necrolysis, Renal dysfunction (with high-dose IV). This list is not exhaustive — consult a qualified clinician.
Who should avoid Glutathione?
Recorded contraindications: Known hypersensitivity to glutathione, Known hypersensitivity to glutathione or formulation excipients, Concurrent chemotherapy regimens where GSH may reduce efficacy, Severe asthma, Pregnancy (high-dose IV). Consult a qualified clinician before use.